Big pharma “tax inversion” deal

Pharmaceutical giants Pfizer and Allergan are in merger talks that could bring blockbuster drugs like Pfizer’s Lyrica, Enbrel and Viagra and Allergan’s Botox and Restasis under one corporate roof

Merger would create world’s largest healthcare group with market value of $332 billion
Market value $219bn
Market value $113bn


Headquarters
Revenue (2014)
Number of employees
Top-selling medications

New York City, U.S.
$49.61 billion
78,000
Lyrica – $5.16 billion (epilepsy, chronic pain)
Viagra – $1.68 billion (erectile dysfunction)


Dublin, Ireland
$72 billion
30,000 
Botox – $2 billion* (anti-wrinkle treatment) 
Restasis – $940 million* (dry-eye treatment )

Tax inversion deal: U.S. company buys foreign company based in low-tax jurisdiction and moves headquarters there to reduce its tax bill U.S. corporation tax: 35% Ireland corporation tax: 12.5%

Sources: Statista, Vault company-profiles
*2013 figures